ProfileGDS5822 / ILMN_1241086
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 34% 26% 21% 10% 3% 23% 64% 8% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.634
GSM1276600PDAC Late Ablation Control 216.226
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 111.521
GSM1276603PDAC Late Ablation 28.610
GSM1276604PDAC Late Ablation 343
GSM1303940PDAC Late Ablation_anti-CTLA4 113.523
GSM1303941PDAC Late Ablation_anti-CTLA4 244.764
GSM1303942PDAC Late Ablation_anti-CTLA4 35.78